{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:36Z","timestamp":1760853816380},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.exppara.2015.01.016","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T17:19:35Z","timestamp":1423070375000},"page":"28-33","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors"],"prefix":"10.1016","volume":"151-152","author":[{"given":"Dietmar","family":"Steverding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2015.01.016_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2015.01.016_bib0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense","volume":"4","author":"Baltz","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.exppara.2015.01.016_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/17460441.3.2.173","article-title":"Recent initiatives and strategies to developing new drugs for tropical parasitic diseases","volume":"3","author":"Caffrey","year":"2008","journal-title":"Expert Opin. Drug Discov"},{"key":"10.1016\/j.exppara.2015.01.016_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2009.04.009","article-title":"Kinetoplastid papain-like cysteine peptidases","volume":"167","author":"Caffrey","year":"2009","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1389450003349290","article-title":"Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy","volume":"1","author":"Caffrey","year":"2000","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.exppara.2015.01.016_bib0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"10.1016\/j.exppara.2015.01.016_bib0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/270347a0","article-title":"Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultures","volume":"270","author":"Collins","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.exppara.2015.01.016_bib0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","article-title":"Drugs and drug resistance in African trypanosomiasis","volume":"10","author":"Delespaux","year":"2007","journal-title":"Drug Resist. Updat"},{"key":"10.1016\/j.exppara.2015.01.016_bib0050","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1021\/jm400294w","article-title":"Vinyl sulfone-based peptidomimetics as anti-trypanosomal agents: design, synthesis, biological and computational evaluation","volume":"56","author":"Dunny","year":"2013","journal-title":"J. Med. Chem"},{"key":"10.1016\/j.exppara.2015.01.016_bib0055","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0166-6851(87)90105-8","article-title":"In vivo effects of difluoromethylormithine on trypanothione and polyamine levels in bloodstream forms of Trypanosoma brucei","volume":"24","author":"Fairlamb","year":"1987","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0031182000000822","article-title":"In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei","volume":"80","author":"Hirumi","year":"1980","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2015.01.016_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop"},{"key":"10.1016\/j.exppara.2015.01.016_bib0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","article-title":"Drug resistance in Trypanosoma brucei ssp., the causative agents of sleeping sickness in man and nagana in cattle","volume":"3","author":"Matovu","year":"2001","journal-title":"Microbes Infect"},{"key":"10.1016\/j.exppara.2015.01.016_bib0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1967.03120080053007","article-title":"Culture of normal human leukocytes","volume":"199","author":"Moore","year":"1967","journal-title":"J. Am. Med. Assoc"},{"key":"10.1016\/j.exppara.2015.01.016_bib0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.110.2.327","article-title":"A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting proteolysis","volume":"110","author":"Pisoni","year":"1990","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0090","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"281","article-title":"Rational selection of anti-microbial drug targets: unique or conserved?","author":"Rodenko","year":"2013"},{"key":"10.1016\/j.exppara.2015.01.016_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/978-1-4419-8414-2_7","article-title":"Cruzain: the path from target validation to the clinic","volume":"712","author":"Sajid","year":"2011","journal-title":"Adv. Exp. Med. Biol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/expr.1998.4381","article-title":"Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-Phe-Ala-CHN2","volume":"91","author":"Scory","year":"1999","journal-title":"Exp. Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2015.01.016_bib0110","series-title":"Trypanosomatid Diseases: Molecular Routes to Drug Discovery","first-page":"365","article-title":"Proteases of Trypanosoma brucei","author":"Steverding","year":"2013"},{"key":"10.1016\/j.exppara.2015.01.016_bib0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1756-3305-6-78","article-title":"Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling","volume":"6","author":"Steverding","year":"2013","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.exppara.2015.01.016_bib0120","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jac\/dkp120","article-title":"Evaluation of anti-sleeping sickness drugs and topoisomerase inhibitors in combination on Trypanosoma brucei","volume":"63","author":"Steverding","year":"2009","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.exppara.2015.01.016_bib0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","article-title":"Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target","volume":"42","author":"Steverding","year":"2012","journal-title":"Int. J. Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0130","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1432-1033.1996.0728w.x","article-title":"Proteases from Trypanosoma brucei brucei. Purification, characterisation and interactions with host regulatory molecules","volume":"238","author":"Troeberg","year":"1996","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.exppara.2015.01.016_bib0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/expr.1998.4386","article-title":"Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei","volume":"91","author":"Troeberg","year":"1999","journal-title":"Exp. Parasitol"},{"key":"10.1016\/j.exppara.2015.01.016_bib0140","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1371\/journal.pntd.0001618","article-title":"Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei","volume":"6","author":"Vincent","year":"2012","journal-title":"PLoS Negl. Trop. Dis"},{"key":"10.1016\/j.exppara.2015.01.016_bib0145","author":"WHO"}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489415000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T16:39:41Z","timestamp":1566319181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489415000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":28,"alternative-id":["S0014489415000272"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2015.01.016","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2015.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}